KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

BioNTech SE (BNTX) Interest Expenses (2018 - 2025)

BioNTech SE's Interest Expenses history spans 8 years, with the latest figure at -$4.9 million for Q4 2025.

  • On a quarterly basis, Interest Expenses rose 63.69% to -$4.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$77.9 million, a 121.29% decrease, with the full-year FY2025 number at -$78.9 million, down 169.34% from a year prior.
  • Interest Expenses hit -$4.9 million in Q4 2025 for BioNTech SE, up from -$29.5 million in the prior quarter.
  • Over the last five years, Interest Expenses for BNTX hit a ceiling of $211.5 million in Q2 2021 and a floor of -$162.3 million in Q4 2022.
  • Historically, Interest Expenses has averaged -$14.9 million across 5 years, with a median of -$7.9 million in 2024.
  • Biggest five-year swings in Interest Expenses: crashed 14815505.28% in 2021 and later soared 95.55% in 2022.
  • Tracing BNTX's Interest Expenses over 5 years: stood at -$2.4 million in 2021, then crashed by 6656.8% to -$162.3 million in 2022, then surged by 83.3% to -$27.1 million in 2023, then soared by 50.34% to -$13.5 million in 2024, then skyrocketed by 63.69% to -$4.9 million in 2025.
  • Business Quant data shows Interest Expenses for BNTX at -$4.9 million in Q4 2025, -$29.5 million in Q3 2025, and -$7.9 million in Q2 2025.